Advertisement

Organisation › Details
Metrion Biosciences Ltd.
Metrion Biosciences is a specialist ion-channel contract research organisation and drug discovery business. The Company provides customers with access to a range of high quality ion channel assays on a fee-for-service or collaboration basis. Metrion Biosciences’ ion channel expertise includes an industry leading panel of in vitro cardiac ion channel safety assays, translational native cell and phenotypic assays for neurological and cardiotoxicity testing, and a range of other ion channel screening services such as cell line development and optimisation. Metrion Biosciences is able to provide tailored assay formats, data analysis and reporting solutions, effective project management and quality assured data packages. *
![]() |
Start | 2015-05-01 established |
Predecessor | Xention Ltd. | |
![]() |
Industry | drug discovery services |
Industry 2 | contract research (drugs) | |
![]() |
Person | Southan, Andrew (Metrion Biosciences 201904– promoted to CEO joined 201610 before CeNeS + Ionix + BioFocus) |
Person 2 | McCullagh, Keith (Santaris Pharma 200506 CEO) | |
![]() |
Region | Babraham, Cambridgeshire |
Country | United Kingdom (GB) | |
Street | Building B501 Babraham Research Campus | |
City | CB22 3AT Babraham, Cambridgeshire | |
Tel | +44-1223-919-100 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Metrion Biosciences Ltd.. (12/20/23). "Press Release: Metrion Biosciences Closes £3.7m New Equity Financing". Cambridge. | ||
Record changed: 2024-11-28 |
Advertisement

More documents for Metrion Biosciences Ltd.
- [1] Metrion Biosciences Ltd.. (11/25/24). "Press Release: Metrion Biosciences Appoints Lee Patterson as CEO". Cambridge....
- [2] Metrion Biosciences Ltd.. (12/20/23). "Press Release: Metrion Biosciences Closes £3.7m New Equity Financing". Cambridge....
- [3] Metrion Biosciences Ltd.. (6/9/22). "Press Release: Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development". Cambridge....
- [4] Metrion Biosciences Ltd.. (12/16/21). "Press Release: Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify novel ion channel inhibitors for autoimmune diseases". Cambridge & Brussels....
- [5] Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge....
- [6] Metrion Biosciences Ltd.. (4/6/21). "Press Release: Metrion Biosciences Closes £2.7m New Equity Financing. Financing Led by Gresham House Ventures". Cambridge....
- [7] Metrion Biosciences Ltd.. (9/8/20). "Press Release: Metrion Biosciences Strengthens Global Business Development Team". Cambridge....
- [8] Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge....
- [9] Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top